Stocks / RCUS / Shares Outstanding

Arcus Biosciences, Inc. Shares Outstanding 2016–2025

Arcus Biosciences, Inc. reported 125.3M of shares outstanding for fiscal 2025. That was 35.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +92.4%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details.

Latest filed value
125.3M
One-year change
+35.9%
Change since 2020
+92.4%
Latest period end
2025-12-31
Arcus Biosciences, Inc. Shares Outstanding history from 2016 to 2025FY 2016: 0FY 2017: 4090898FY 2018: 44537946FY 2019: 45925004FY 2020: 65114685FY 2021: 70800000FY 2022: 72900000FY 2023: 75500000FY 2024: 92200000FY 2025: 125300000
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearShares OutstandingChange (YoY)
FY 2025125.3M+35.9%
FY 202492.2M+22.1%
FY 202375.5M+3.6%
FY 202272.9M+3.0%
FY 202170.8M+8.7%
FY 202065.1M+41.8%
FY 201945.9M+3.1%
FY 201844.5M+988.7%
FY 20174.1M—
FY 20160.0M—

Source: Arcus Biosciences, Inc. SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open RCUS 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

Arcus Biosciences, Inc. reported 125.3M of shares outstanding for fiscal 2025. That was 35.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +92.4%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for Arcus Biosciences, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Arcus Biosciences, Inc. — frequently asked questions

What is Arcus Biosciences, Inc.'s shares outstanding?

Arcus Biosciences, Inc. (RCUS) reported shares outstanding of 125.3M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Arcus Biosciences, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.

More RCUS financial history

RCUS revenueRCUS net incomeRCUS gross profitRCUS eps (earnings per share)RCUS ebitdaRCUS free cash flowRCUS total debtRCUS dividend historyRCUS p/e ratio

Full RCUS fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →